Manufacturing and Production

Showing 15 posts of 5863 posts found.

john-mckew-big

Dr John C. McKew promoted to Chief Operating Officer at Lumos Pharma

April 3, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Lumos Pharma, Inc. has promoted Dr John McKew to the position of Chief Operating Officer effective 1 April 2020. McKew …
alimera_sciences_logo

Steven T Gill returns to Alimera as VP, Thought Leader Engagement

April 3, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alimera Sciences, Novartis, pharma

Ophthalmology specialist Alimera Sciences has announced that Steven T Gill is to return to the company in the newly created …
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

April 3, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus

COVID-19 coronavirus treatments dominate the news as the world looks for a vaccine. Johnson & Johnson announced that it has …

Axsome’s late-stage study of experimental depression drug misses main trial goal

March 31, 2020 Manufacturing and Production Depressive Disorder, MDD, depression, migraine

Axsome Therapeutics reported on Monday that its Phase 3 study of its experimental depression drug missed its main trial goal. …
000_jjjj

Johnson & Johnson selects lead COVID-19 vaccine candidate and targets September Phase I study

March 31, 2020 Manufacturing and Production . Johnson & Johnson, Johnson & Johnson, Vaccine, coronavirus, coronavirus vaccine

Johnson & Johnson announced that it has selected a candidate for a COVID-19 vaccine from potential constructs it has been …

Bayer’s Nubeqa combo approved in Europe for non-metastatic castration-resistant prostate cancer

March 31, 2020 Manufacturing and Production, Research and Development Bayer, Cancer, Europe, Nubeqa, prostate cancer

The European Commission has given the green light to Bayer’s non-steroidal androgen receptor inhibitor Nubeqa (darolutamide), jointly developed with Orion, …
000_parliiii

UK social distancing measures making a difference to the spread of COVID-19, government says

March 31, 2020 Manufacturing and Production British Coronavirus, COVID-`9, coronavirus, coronavirus uk

Social distancing measures are slowing down the spread of coronavirus and keeping pressure off the NHS, according to the UK’s …
shutterstock_212432119

EUSA Pharma and Ergomed partner to investigate IL-6 targeting in COVID-19 patients with serious respiratory complications

March 31, 2020 Manufacturing and Production, Research and Development COVID-19, Eusa Pharma, coronavirus, ergomed, pharma

Oncology and rare disease firm EUSA Pharma is aiding in the global fight against the novel coronavirus with the launch …
medications-257333_640

People or profit: What is the best system to regulate drug prices?

March 30, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Conor Kavanagh investigates the role state healthcare institutions play in negotiating drug prices, and what steps can be taken for …
gary-jacob-cropped

Immunron Chief Executive Officer Gary Jacob resigns amidst coronavirus cost-cutting

March 27, 2020 Manufacturing and Production

The Chief Executive Officer of Immuron, Gary S. Jacob, has resigned as CEO and as a member of the Board …
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

March 27, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus

The COVID-19 global pandemic continues to dominate the news cycle. The first clinical trial using danoprevir (Ganovo) in treating COVID-19 …

Roche shows improved survival rates in new treatment for untreated acute myeloid leukaemia

March 24, 2020 Manufacturing and Production Cancer, Roche, acute myeloid leukamia

Roche has announced that its clinical trials for Venclexta/Venclyzto combination with azacitidine have met its primary endpoints of overall survival …
screen_shot_2020-01-29_at_16

Sustainability and security: How packaging is modernising pharma

March 24, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing counterfeit medicines, falsified medicines, feature, packaging, pharma

In a world living in the shadow of substandard and falsified medicines, climate change and antimicrobial resistance, pharmaceutical packaging will …

Nanovax’s seasonal flu vaccine meets Phase 3 endpoints and matches Sanofi’s Fluzone

March 24, 2020 Manufacturing and Production, Research and Development NanoFlu, Nanovax, influenza, pharma

Nanovax has reported positive Phase 3 data for its vaccine NanoFlu, with the candidate meeting its primary endpoints in the …
The Gateway to Local Adoption Series

Latest content